(XISE) FT Cboe Vest U.S. Equity - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome
XISE: Options, Treasury Securities
The FT Cboe Vest U.S. Equity Buffer & Premium Income ETF – September (BATS:XISE) is designed to provide investors with exposure to the price performance of an underlying ETF while incorporating a buffer against losses. Under normal market conditions, the fund allocates the majority of its assets to Flex Options, which are exchange-traded options that allow for customized outcomes. These options are tied to the performance of the underlying ETF, and the fund also invests in short-term U.S. Treasury securities to manage risk and generate additional income. The fund is classified as non-diversified, meaning it may concentrate its investments in a smaller number of securities, which can increase risk but also potentially enhance returns. The ETF is part of the Defined Outcome category, which typically seeks to deliver specific risk-return profiles, such as buffered losses or enhanced income.
Additional Sources for XISE ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
XISE ETF Overview
Market Cap in USD | 68m |
Category | Defined Outcome |
TER | 0.85% |
IPO / Inception | 2023-09-15 |
XISE ETF Ratings
Growth 5y | 52.0% |
Fundamental | - |
Dividend | 44.5% |
Rel. Strength Industry | -3.66 |
Analysts | - |
Fair Price Momentum | 28.85 USD |
Fair Price DCF | - |
XISE Dividends
Dividend Yield 12m | 6.32% |
Yield on Cost 5y | 6.83% |
Annual Growth 5y | 140.70% |
Payout Consistency | 66.7% |
XISE Growth Ratios
Growth Correlation 3m | 53.2% |
Growth Correlation 12m | 98.6% |
Growth Correlation 5y | 99.5% |
CAGR 5y | 5.89% |
CAGR/Max DD 5y | 3.94 |
Sharpe Ratio 12m | 0.85 |
Alpha | -0.29 |
Beta | 0.09 |
Volatility | 4.82% |
Current Volume | 7.5k |
Average Volume 20d | 10.5k |
As of March 14, 2025, the stock is trading at USD 29.83 with a total of 7,548 shares traded.
Over the past week, the price has changed by -0.52%, over one month by -1.25%, over three months by -0.14% and over the past year by +4.27%.
Partly, yes. Based on ValueRay Analyses, FT Cboe Vest U.S. Equity (BATS:XISE) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 52.04 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XISE as of March 2025 is 28.85. This means that XISE is currently overvalued and has a potential downside of -3.29%.
FT Cboe Vest U.S. Equity has no consensus analysts rating.
According to ValueRays Forecast Model, XISE FT Cboe Vest U.S. Equity will be worth about 31.2 in March 2026. The stock is currently trading at 29.83. This means that the stock has a potential upside of +4.46%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 31.2 | 4.5% |